Your browser doesn't support javascript.
loading
Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response.
Siproudhis, L; Graf, W; Emmanuel, A; Walker, D; Shing, R Ng Kwet; Pediconi, C; Pilot, J; Wexner, S; Scholefield, J.
Afiliação
  • Siproudhis L; CHU Pontchaillou, Rennes, France.
  • Graf W; Institution of Surgical Sciences, Akademiska Sjukhuset, Uppsala University, 75185, Uppsala, Sweden.
  • Emmanuel A; University College Hospital, 235 Euston Road, London, UK.
  • Walker D; Norgine Ltd, Norgine House, Widewater Place, Moorhall Road, Uxbridge, UB9 6NS, UK. dwalker@norgine.com.
  • Shing RN; Norgine Ltd, Norgine House, Widewater Place, Moorhall Road, Uxbridge, UB9 6NS, UK.
  • Pediconi C; Norgine Ltd, Norgine House, Widewater Place, Moorhall Road, Uxbridge, UB9 6NS, UK.
  • Pilot J; Norgine Ltd, Norgine House, Widewater Place, Moorhall Road, Uxbridge, UB9 6NS, UK.
  • Wexner S; Cleveland Clinic Florida, Weston, FL, USA.
  • Scholefield J; Division of Surgery, University Hospital Nottingham, Nottingham, UK.
Int J Colorectal Dis ; 31(6): 1205-16, 2016 Jun.
Article em En | MEDLINE | ID: mdl-27075314

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Incontinência Fecal / Metoxamina Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Incontinência Fecal / Metoxamina Idioma: En Ano de publicação: 2016 Tipo de documento: Article